Strides Pharma Science Ltd

Common Name
Strides Pharma Science
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3,301
Ticker
STAR
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Strides Pharma Science Ltd. is a prominent pharmaceutical company engaged in the development, manufacturing, and marketing of a wide array of pharmaceutical products. The primary function of Strides P...

Strides Pharma Science's GHG Emissions Data Preview

In 2023, Strides Pharma Science completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Strides Pharma Science has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Strides Pharma Science’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Strides Pharma Science’s data sources below and access millions more through our Disclosure Search.

a. Strides Pharma Science's Annual Report 2023
a. Strides Pharma Science's Annual Report 2023

Insights into Strides Pharma Science's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Strides Pharma Science amounted to 25,553 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Strides Pharma Science decreased by 2.34%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

Strides Pharma Science's Scope 1 Emissions Over Time

2022202302 k4 k6 k8 ktCO2e-1%
  • Total Scope 1
  • Year-over-Year Change

What are Strides Pharma Science's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Strides Pharma Science were 6,168 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2022), Strides Pharma Science's Scope 1 emissions remained relatively stable, indicating that Strides Pharma Science's emissions have plateaued with no significant change in its operational footprint. a

What are Strides Pharma Science's Scope 2 emissions?

In 2023, Strides Pharma Science reported Scope 2 greenhouse gas (GHG) emissions of 19,385 tCO₂e without specifying the calculation method. a

Has Strides Pharma Science reduced its Scope 2 emissions over time?

Compared to the previous year (2022), Strides Pharma Science's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Strides Pharma Science 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Strides Pharma Science use for Scope 2 reporting?

In 2023, Strides Pharma Science reported its Scope 2 emissions using an unspecified methodology. a

Strides Pharma Science's Scope 2 Emissions Over Time

2022202305 k10 k15 k20 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Strides Pharma Science’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Strides Pharma Science reported Scope 1 greenhouse gas (GHG) emissions of 6,168 tCO₂e and total revenues of USD 439 millions. This translates into an emissions intensity of 14.04 tCO₂e per millions USD. a

Strides Pharma Science's Scope 1 Emissions Intensity Compared to Peers

1001,00020,000200,0002,000,000Scope 1 Emissions (tCO2e)502001,0002,00010,000Revenues (Millions of USD)OJIOLCPYear: 2025Scope 1: 45,920 tCO2eRevenue: $M 242Scope 1 Intensity: 189.70 tCO2e/$MDivi's LaboratoriesYear: 2025Scope 1: 339,941 tCO2eRevenue: $M 1,091Scope 1 Intensity: 311.47 tCO2e/$MAurobindo PharmaYear: 2025Scope 1: 750,616 tCO2eRevenue: $M 3,672Scope 1 Intensity: 204.39 tCO2e/$MMankind PharmaYear: 2025Scope 1: 6,538 tCO2eRevenue: $M 1,429Scope 1 Intensity: 4.58 tCO2e/$MZydus LifesciencesYear: 2023Scope 1: 44,792 tCO2eRevenue: $M 2,056Scope 1 Intensity: 21.79 tCO2e/$MAarti PharmalabsYear: 2024Scope 1: 88,101 tCO2eRevenue: $M 218Scope 1 Intensity: 404.68 tCO2e/$MAlembic PharmaceuticalsYear: 2025Scope 1: 80,278 tCO2eRevenue: $M 765Scope 1 Intensity: 104.88 tCO2e/$MAjanta PharmaYear: 2025Scope 1: 6,392 tCO2eRevenue: $M 537Scope 1 Intensity: 11.90 tCO2e/$MAbbott IndiaYear: 2025Scope 1: 232 tCO2eRevenue: $M 750Scope 1 Intensity: 0.31 tCO2e/$MCiplaYear: 2025Scope 1: 38,283 tCO2eRevenue: $M 3,177Scope 1 Intensity: 12.05 tCO2e/$MJB PharmaYear: 2025Scope 1: 5,652 tCO2eRevenue: $M 452Scope 1 Intensity: 12.50 tCO2e/$MNatco PharmaYear: 2025Scope 1: 28,495 tCO2eRevenue: $M 518Scope 1 Intensity: 54.96 tCO2e/$MGlenmark PharmaceuticalsYear: 2025Scope 1: 34,547 tCO2eRevenue: $M 1,539Scope 1 Intensity: 22.45 tCO2e/$MTorrent PharmaceuticalsYear: 2025Scope 1: 8,937 tCO2eRevenue: $M 1,325Scope 1 Intensity: 6.75 tCO2e/$MCohance LifesciencesYear: 2025Scope 1: 31,818 tCO2eRevenue: $M 140Scope 1 Intensity: 227.00 tCO2e/$MOOOrchid PharmaYear: 2025Scope 1: 74,800 tCO2eRevenue: $M 108Scope 1 Intensity: 693.22 tCO2e/$MAlkem LaboratoriesYear: 2025Scope 1: 33,018 tCO2eRevenue: $M 1,499Scope 1 Intensity: 22.03 tCO2e/$MGland PharmaYear: 2025Scope 1: 13,920 tCO2eRevenue: $M 654Scope 1 Intensity: 21.30 tCO2e/$MLupinYear: 2025Scope 1: 82,174 tCO2eRevenue: $M 2,597Scope 1 Intensity: 31.64 tCO2e/$MSun Pharmaceutical IndustriesYear: 2025Scope 1: 156,242 tCO2eRevenue: $M 6,091Scope 1 Intensity: 25.65 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MIPCA LaboratoriesYear: 2025Scope 1: 169,992 tCO2eRevenue: $M 1,036Scope 1 Intensity: 164.03 tCO2e/$MJJJubilant PharmovaYear: 2025Scope 1: 10,084 tCO2eRevenue: $M 842Scope 1 Intensity: 11.98 tCO2e/$MGranules IndiaYear: 2024Scope 1: 58,254 tCO2eRevenue: $M 538Scope 1 Intensity: 108.19 tCO2e/$MStrides Pharma ScienceYear: 2023Scope 1: 6,168 tCO2eRevenue: $M 439Scope 1 Intensity: 14.04 tCO2e/$M

How does Strides Pharma Science's GHG emissions intensity compare to its peers?

In 2023, Strides Pharma Science reported a Scope 1 emissions intensity of 14.04 tCO₂e per millions USD. Compared to the peer group median of 28.64 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Strides Pharma Science rank on GHG emissions intensity within its industry?

In 2023, Strides Pharma Science ranked 8 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Strides Pharma Science is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Strides Pharma Science's GHG Emissions Dataset?
Sign Up